Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - AVADEL PHARMACEUTICALS PLCv433294_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - AVADEL PHARMACEUTICALS PLCv433294_ex31-2.htm
EX-21.1 - EXHIBIT 21.1 - AVADEL PHARMACEUTICALS PLCv433294_ex21-1.htm
EX-32.1 - EXHIBIT 32.1 - AVADEL PHARMACEUTICALS PLCv433294_ex32-1.htm
EX-10.20 - EXHIBIT 10.20 - AVADEL PHARMACEUTICALS PLCv433294_ex10-20.htm
EX-10.19 - EXHIBIT 10.19 - AVADEL PHARMACEUTICALS PLCv433294_ex10-19.htm
EX-10.23 - EXHIBIT 10.23 - AVADEL PHARMACEUTICALS PLCv433294_ex10-23.htm
EX-10.18 - EXHIBIT 10.18 - AVADEL PHARMACEUTICALS PLCv433294_ex10-18.htm
EX-10.17 - EXHIBIT 10.17 - AVADEL PHARMACEUTICALS PLCv433294_ex10-17.htm
EX-10.22 - EXHIBIT 10.22 - AVADEL PHARMACEUTICALS PLCv433294_ex10-22.htm
EX-10.25 - EXHIBIT 10.25 - AVADEL PHARMACEUTICALS PLCv433294_ex10-25.htm
EX-10.15 - EXHIBIT 10.15 - AVADEL PHARMACEUTICALS PLCv433294_ex10-15.htm
EX-10.24 - EXHIBIT 10.24 - AVADEL PHARMACEUTICALS PLCv433294_ex10-24.htm
EX-10.14 - EXHIBIT 10.14 - AVADEL PHARMACEUTICALS PLCv433294_ex10-14.htm
EX-10.21 - EXHIBIT 10.21 - AVADEL PHARMACEUTICALS PLCv433294_ex10-21.htm
EX-10.26 - EXHIBIT 10.26 - AVADEL PHARMACEUTICALS PLCv433294_ex10-26.htm
10-K - FORM 10-K - AVADEL PHARMACEUTICALS PLCv433294_10k.htm
EX-32.2 - EXHIBIT 32.2 - AVADEL PHARMACEUTICALS PLCv433294_ex32-2.htm
EX-10.16 - EXHIBIT 10.16 - AVADEL PHARMACEUTICALS PLCv433294_ex10-16.htm

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-137844, 333-134638, 333-111725, 333-109693, 333-12542 and 333-177591) of Flamel Technologies S.A. of our report dated March 15, 2016 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

 

Lyon, France,

March 15, 2016

 

PricewaterhouseCoopers Audit

 

Represented by  
/s/ Frederic Charcosset  
Frederic Charcosset